Výsledky vyhledávání - "Ladigan, Swetlana"

Akademický článek

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Akademický článek

Secondary resistance to anti-EGFR therapy by transcriptional reprogramming in patient-derived colorectal cancer models.

Autor: Vangala, Deepak^1,2 (AUTHOR), Ladigan, Swetlana^1,2 (AUTHOR), Liffers, Sven T.^3,4 (AUTHOR), Noseir, Soha¹ (AUTHOR), Maghnouj, Abdelouahid¹ (AUTHOR), Götze, Tina-Maria¹ (AUTHOR), Verdoodt, Berlinda³ (AUTHOR), Klein-Scory, Susanne² (AUTHOR), Godfrey, Laura^5,6 (AUTHOR), Zowada, Martina K.^7,8 (AUTHOR), Huerta, Mario^7,9 (AUTHOR), Edelstein, Daniel L.¹⁰ (AUTHOR), de Villarreal, Jaime Martinez¹¹ (AUTHOR), Marqués, Miriam¹¹ (AUTHOR), Kumbrink, Jörg^12,13 (AUTHOR), Jung, Andreas^12,13 (AUTHOR), Schiergens, Tobias¹⁴ (AUTHOR), Werner, Jens¹⁴ (AUTHOR), Heinemann, Volker¹⁵ (AUTHOR), Stintzing, Sebastian¹⁶ (AUTHOR)

Publikováno v: Genome Medicine. 7/16/2021, Vol. 13 Issue 1, p1-25. 25p.

Zobrazit plný text záznamu

Plný text ve formátu HTML

Altered T-Lymphocyte Biology Following High-Dose Melphalan and Autologous Stem Cell Transplantation With Implications for Adoptive T-Cell Therapy

Autor: Mika, Thomas (Dr. med.), Ladigan, Swetlana (Dr. med.), Maghnouj, Abdelouahid (Dr. rer. nat.), Mustafa, Bakr, Klein-Scory, Susanne (Dr. rer. nat.), Baraniskin, Alexander (Prof. Dr. med.), Döhring, Sascha, Fuchs, Ilka (Dr. med.), Ehl, Stephan (Prof. Dr. med.), Hahn, Stephan (Prof. Dr. med.), Schroers, Roland (Prof. Dr. med.)

Publikováno v: Frontiers in Oncology

In relapsed and refractory multiple myeloma (MM), adoptive cell therapies (ACT) including CAR-T-cells are under clinical investigation. However, relapse due to T-cell exhaustion or limited persistence is an obstacle. Before ACT are considered in MM,

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::72fbf3832bcda57cbea3b71f6465aec0
http://europepmc.org/articles/PMC7759611

Zobrazit plný text záznamu

Evolution of RAS Mutational Status in Liquid Biopsies During First-Line Chemotherapy for Metastatic Colorectal Cancer

Autor: Klein-Scory, Susanne, Wahner, Ingo, Maslova, Marina, Al-Sewaidi, Yosef, Pohl, Michael, Mika, Thomas, Ladigan, Swetlana, Schroers, Roland, Baraniskin, Alexander

Publikováno v: Frontiers in Oncology

Treatment options for patients with metastatic colorectal cancer (mCRC) are limited. This particularly affects the largest group of patients with RAS mutations, who are considered ineligible for therapy with antiEGFR antibodies. In this liquid biopsy

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::879b0792b30863e80bdedfecd97327fc
http://europepmc.org/articles/PMC7378792

Zobrazit plný text záznamu

Refractory Epstein-Barr Virus (EBV)-related post-transplant lymphoproliferative disease

Autor: Mika, Thomas (Dr. med.), Strate, Katharina (Dr. med.), Ladigan, Swetlana (Dr. med.), Aigner, Clemens (Prof. Dr. med.), Schlegel, Uwe (Prof. Dr. med.), Tischoff, Iris, Tischer-Zimmermann, Sabine (Dr. rer. nat.), Eiz-Vesper, Britta (Prof. Dr. rer. nat.), Maecker-Kolhoff, Britta (Prof. Dr. med.), Schroers, Roland (Prof. Dr. med.)

Post-transplant lymphoproliferative disease (PTLD) represents a serious complication following allogeneic hematopoietic stem cell transplantation (alloHSCT). Previously, survival rates of PTLD have improved due to the introduction of rituximab. Howev

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od______3579::22d94cfe08969c7e4673a8b45486cf6e
https://hss-opus.ub.ruhr-uni-bochum.de/opus4/frontdoor/index/index/docId/7748